Literature DB >> 7821103

Helicobacter pylori infection. A reversible cause of hypergastrinemia and hyperchlorhydria which may mimic Zollinger-Ellison syndrome.

D C Metz1, H C Weber, M Orbuch, D B Strader, I A Lubensky, R T Jensen.   

Abstract

The present report describes two patients with fasting hypergastrinemia, gastric acid hypersecretion, and Helicobacter pylori gastritis. Provocative testing for Zollinger-Ellison syndrome was negative and imaging studies did not demonstrate an intra-abdominal mass. Following eradication of the Helicobacter pylori infection, the fasting hypergastrinemia resolved in both patients and in one patient the gastric acid hypersecretion also resolved. The implications of this case on the differential diagnosis of Zollinger-Ellison syndrome are discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7821103     DOI: 10.1007/bf02063959

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  32 in total

1.  THE ZOLLINGER-ELLISON SYNDROME: RE-APPRAISAL AND EVALUATION OF 260 REGISTERED CASES.

Authors:  E H ELLISON; S D WILSON
Journal:  Ann Surg       Date:  1964-09       Impact factor: 12.969

2.  Reliability of symptoms in assessing control of gastric acid secretion in patients with Zollinger-Ellison syndrome.

Authors:  J P Raufman; S M Collins; S J Pandol; L Y Korman; M J Collen; M J Cornelius; M K Feld; D M McCarthy; J D Gardner; R T Jensen
Journal:  Gastroenterology       Date:  1983-01       Impact factor: 22.682

3.  Campylobacter pylori and duodenal ulcers: the gastrin link.

Authors:  S Levi; K Beardshall; G Haddad; R Playford; P Ghosh; J Calam
Journal:  Lancet       Date:  1989-05-27       Impact factor: 79.321

4.  Treatment of Campylobacter pylori does not alter gastric acid secretion.

Authors:  J R Montbriand; H D Appelman; E K Cotner; T T Nostrant; G H Elta
Journal:  Am J Gastroenterol       Date:  1989-12       Impact factor: 10.864

5.  Prospective study of gastrinoma localization and resection in patients with Zollinger-Ellison syndrome.

Authors:  J A Norton; J L Doppman; M J Collen; J W Harmon; P N Maton; J D Gardner; R T Jensen
Journal:  Ann Surg       Date:  1986-10       Impact factor: 12.969

Review 6.  Zollinger-Ellison syndrome. Current concepts in diagnosis and management.

Authors:  M M Wolfe; R T Jensen
Journal:  N Engl J Med       Date:  1987-11-05       Impact factor: 91.245

7.  Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome.

Authors:  J R Pisegna; J A Norton; G G Slimak; D C Metz; P N Maton; J D Gardner; R T Jensen
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

8.  Influence of Helicobacter pylori, sex, and age on serum gastrin and pepsinogen concentrations in subjects without symptoms and patients with duodenal ulcers.

Authors:  S Mossi; B Meyer-Wyss; E L Renner; H S Merki; G Gamboni; C Beglinger
Journal:  Gut       Date:  1993-06       Impact factor: 23.059

9.  Prospective study of the use of intraarterial secretin injection and portal venous sampling to localize duodenal gastrinomas.

Authors:  A K Thom; J A Norton; J L Doppman; D L Miller; R Chang; R T Jensen
Journal:  Surgery       Date:  1992-12       Impact factor: 3.982

10.  Family studies of hypergastrinemic, hyperpepsinogenemic I duodenal ulcer.

Authors:  I L Taylor; J Calam; J I Rotter; C Vaillant; I M Samloff; A Cook; E Simkin; G J Dockray
Journal:  Ann Intern Med       Date:  1981-10       Impact factor: 25.391

View more
  4 in total

1.  Mechanism of acid hypersecretion post curative gastrinoma resection.

Authors:  Jeremiah V Ojeaburu; Tetsuhide Ito; Pellegrino Crafa; Cesare Bordi; Robert T Jensen
Journal:  Dig Dis Sci       Date:  2010-08-20       Impact factor: 3.199

2.  Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing.

Authors:  David C Metz; Guillaume Cadiot; Pierre Poitras; Tetsuhide Ito; Robert T Jensen
Journal:  Int J Endocr Oncol       Date:  2017-10-11

Review 3.  Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases.

Authors:  Marc J Berna; Robert T Jensen
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

Review 4.  Hypergastrinemia.

Authors:  Sunil Dacha; Mohammed Razvi; Julia Massaad; Qiang Cai; Mohammad Wehbi
Journal:  Gastroenterol Rep (Oxf)       Date:  2015-02-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.